How MICHR is Helping Researchers Battle COVID-19
Every day brings more news of the progression of the COVID-19 pandemic. Epidemiologists and researchers around the world are racing the clock to find an answer to stop COVID-19, and together, we will. The Michigan Institute for Clinical & Health Research is taking important steps to aid researchers in the battle against COVID-19.
MICHR remains open for business.
Our team of nearly 100 is working remotely to continue educating, funding, connecting, and supporting your teams as best we can. As usual, you can contact us at any time by emailing UM-MICHR@umich.edu to let us know what we can do for you.
Featured COVID-19-Related Services
MICHR has launched the Promoting Academics and Community Engagement (PACE) Dissemination Grant to support community-academic partnerships in sharing Community-Engaged Research (CEnR) results back to the community.
The Community Engagement (CE) Studio provides an opportunity for researchers to enhance their research project during an interactive session with patients, caregivers, health care providers, community members, and other non-researcher stakeholders.
The Network-Based Research Unit (NBRU) is a singular unit within MICHR that facilitates health-related network-based research for the University of Michigan. The Unit assists investigators, industry, and patient communities, in linking to and designing studies that utilize large-scale research consortia. Learn more on the NBRU overview page.
ClinicalTrials.gov is a database of privately and publicly funded clinical studies conducted around the world. You may be required to register your trial and post results on this website in order to meet legal or contractual obligations. MICHR can help you register your clinical trial and can also provide ongoing support.
MICHR’s expanded access support provides assistance for physicians throughout the process of requesting single patient expanded access.
Our free in-person consultations offer personalized support and advice for your grant proposals or research ideas and are available to any U-M investigator.
Our monitors will follow standard operating procedures and detailed monitoring plans (written in conjunction with the investigator) to provide a tailored approach for monitoring needs.
MICHR can help determine whether our engaged participant registry, UMHealthResearch.org is an appropriate recruitment tool for your study and, if it is, teach you how to maximize the potential of UMHealthResearch.org for your study.
MICHR can help you develop and review recruitment materials, identifying obstacles that may affect participant recruitment for your study.
Learn more about what MICHR is doing in the fight against COVID-19
A new groundbreaking study from the University of Michigan’s Center for Drug Repurposing (CDR) reveals several drug contenders already in use for other purposes—including one dietary supplement—that have been shown to block or reduce SARS-CoV-2 infection in cells.
The study, published recently in the Proceedings of the National Academy of Sciences, uses artificial intelligence-powered image analysis of human cell lines during infection with the novel coronavirus.
Michigan CEAL: Communities Conquering COVID, a member of the National Institutes of Health (NIH) funded initiative Community Engagement Alliance (CEAL) Against COVID-19 Disparities, has been awarded an additional $1.4 million dollars to support an additional year of community-based COVID-19 interventions. The Michigan CEAL project was previously funded $1.4 million in the Fall of 2020.
Connected to U-M through MICHR’s Network Based Research Unit, the National COVID Cohort Collaborative aims to improve the efficiency and accessibility of analyses with COVID-19 clinical data, expand researchers’ ability to analyze and understand COVID, and demonstrate a novel approach for collaborative pandemic data sharing.
An interdisciplinary team of researchers from across the University of Michigan, including the Institute of Social Research and the Michigan Institute for Clinical & Health Research (MICHR), have published a new comprehensive toolkit to help patients and caregivers navigate the COVID journey every step of the way.
Researchers across Michigan Medicine may now request access to the ACT (Accrual to Clinical Trials) Network, which can be used to explore and validate feasibility for participating CTSA multi-site clinical studies using electronic health record data.
Michigan Communities Conquering COVID (MiCCC) has launched “Take the Mic,” a contest celebrating everyday heroes saving lives one precautionary measure at a time.
Being deeply rooted in the wellbeing of Michigan communities meant that the Community Engagement program at the (MICHR), Michigan Medicine, and the U-M School of Public Health (SPH) were on the frontlines when the pandemic hit the nation. They witnessed a significant imbalance in support for low income and communities of color across the state, so MICHR and SPH came together to launch a program called, “’The Fierce Urgency of Now’: Communities Conquering COVID (C3).”
Beginning with a human-centered design consultation, MICHR’s Innovation team partners with teams across U-M to help transform research ideas into people-centered interventions.
Are you a mentor looking to learn how to best support your mentees in the time of COVID? Attend “Mentoring in a Time of COVID-19,” cosponsored by MICHR, the Medical School Office of Graduate and Postdoctoral Studies, and Rackham Graduate School.
Michigan Medicine is partnering with sponsor AstraZeneca in a multi-site, international effort researching an investigational vaccine for the prevention of COVID-19.
COVID-19 related resources
The Community Engagement team has created community-focused flyers at an accessible reading level with information regarding COVID-19.
MICHR’s biostatistics team consults and collaborates with researchers to provide expertise in all of your statistics needs.